Table 7 ROC curve analysis for predicting osteoporosis or osteopenia in the hip

Total

 TC (mmol/l)

0.130

0.556 (0.487–0.625)

5.635

0.387

0.743

0.110

 FFA (mmol/l)

0.326

0.687 (0.624–0.749)

0.514

0.589

0.737

<0.001

 IL-6 (pg/ml)

0.342

0.699 (0.636–0.762)

7.650

0.645

0.697

<0.001

 ApoA1 (g/l)

0.144

0.584 (0.517–0.651)

1.345

0.532

0.612

0.016

 ApoA1/ApoB

0.092

0.536 (0.468–0.605)

1.214

0.645

0.447

0.299

 Joint Indicators–1

0.509

0.795 (0.742–0.848)

/

0.726

0.783

<0.001

 Joint Indicators–2

0.485

0.803 (0.751–0.855)

/

0.774

0.711

<0.001

 Joint Indicators–3

0.497

0.803 (0.751–0.855)

/

0.734

0.763

<0.001

Male

 TC (mmol/l)

0.191

0.556 (0.436–0.676)

5.605

0.368

0.823

0.349

 FFA (mmol/l)

0.256

0.651 (0.541–0.761)

0.474

0.579

0.677

0.011

 IL-6 (pg/ml)

0.379

0.715 (0.607–0.822)

9.400

0.605

0.774

<0.001

 ApoA1/ApoB

0.139

0.500 (0.379–0.622)

1.468

0.823

0.316

0.994

 Joint Indicators–1

0.519

0.775 (0.677–0.873)

/

0.632

0.887

<0.001

 Joint Indicators–2

0.507

0.792 (0.701-0.884)

/

0.684

0.823

<0.001

Female

 TC (mmol/l)

0.096

0.535 (0.449–0.620)

5.645

0.407

0.689

0.424

 FFA (mmol/l)

0.361

0.701 (0.624–0.779)

0.518

0.628

0.733

<0.001

 IL-6 (pg/ml)

0.387

0.701 (0.623–0.779)

6.250

0.698

0.689

<0.001

 ApoA1 (g/l)

0.146

0.572 (0.487–0.656)

1.425

0.535

0.611

0.101

 ApoA1/ApoB

0.133

0.532 (0.446–0.618)

1.214

0.733

0.400

0.464

 Joint Indicators–1

0.535

0.801 (0.735–0.867)

/

0.779

0.756

<0.001

 Joint Indicators–2

0.478

0.801 (0.736–0.866)

/

0.767

0.711

<0.001

 Joint Indicators–3

0.545

0.803 (0.738–0.869)

/

0.767

0.778

<0.001